100 related articles for article (PubMed ID: 23117118)
1. Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer.
Drenckhan A; Kurschat N; Dohrmann T; Raabe N; Koenig AM; Reichelt U; Kaifi JT; Izbicki JR; Gros SJ
J Surg Res; 2013 Jun; 182(2):250-6. PubMed ID: 23117118
[TBL] [Abstract][Full Text] [Related]
2. A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer.
Huang EH; Singh B; Cristofanilli M; Gelovani J; Wei C; Vincent L; Cook KR; Lucci A
J Surg Res; 2009 Aug; 155(2):231-6. PubMed ID: 19482312
[TBL] [Abstract][Full Text] [Related]
3. CXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma.
Gros SJ; Graeff H; Drenckhan A; Kurschat N; Blessmann M; Rawnaq T; Izbicki JR
In Vivo; 2012; 26(4):711-8. PubMed ID: 22773586
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.
Richert MM; Vaidya KS; Mills CN; Wong D; Korz W; Hurst DR; Welch DR
Oncol Rep; 2009 Mar; 21(3):761-7. PubMed ID: 19212637
[TBL] [Abstract][Full Text] [Related]
5. CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model.
Hassan S; Buchanan M; Jahan K; Aguilar-Mahecha A; Gaboury L; Muller WJ; Alsawafi Y; Mourskaia AA; Siegel PM; Salvucci O; Basik M
Int J Cancer; 2011 Jul; 129(1):225-32. PubMed ID: 20830712
[TBL] [Abstract][Full Text] [Related]
6. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer.
Singh B; Cook KR; Martin C; Huang EH; Mosalpuria K; Krishnamurthy S; Cristofanilli M; Lucci A
Clin Exp Metastasis; 2010 Apr; 27(4):233-40. PubMed ID: 20229045
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases.
Kim SY; Lee CH; Midura BV; Yeung C; Mendoza A; Hong SH; Ren L; Wong D; Korz W; Merzouk A; Salari H; Zhang H; Hwang ST; Khanna C; Helman LJ
Clin Exp Metastasis; 2008; 25(3):201-11. PubMed ID: 18071913
[TBL] [Abstract][Full Text] [Related]
9. Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.
Wong D; Kandagatla P; Korz W; Chinni SR
BMC Urol; 2014 Jan; 14():12. PubMed ID: 24472670
[TBL] [Abstract][Full Text] [Related]
10. Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016.
Otani Y; Kijima T; Kohmo S; Oishi S; Minami T; Nagatomo I; Takahashi R; Hirata H; Suzuki M; Inoue K; Takeda Y; Kida H; Tachibana I; Fujii N; Kumanogoh A
FEBS Lett; 2012 Oct; 586(20):3639-44. PubMed ID: 22992418
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.
Gros SJ; Kurschat N; Drenckhan A; Dohrmann T; Forberich E; Effenberger K; Reichelt U; Hoffman RM; Pantel K; Kaifi JT; Izbicki JR
PLoS One; 2012; 7(10):e47287. PubMed ID: 23082154
[TBL] [Abstract][Full Text] [Related]
12. Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth.
Porvasnik S; Sakamoto N; Kusmartsev S; Eruslanov E; Kim WJ; Cao W; Urbanek C; Wong D; Goodison S; Rosser CJ
Prostate; 2009 Sep; 69(13):1460-9. PubMed ID: 19588526
[TBL] [Abstract][Full Text] [Related]
13. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
14. CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.
Yoon Y; Liang Z; Zhang X; Choe M; Zhu A; Cho HT; Shin DM; Goodman MM; Chen ZG; Shim H
Cancer Res; 2007 Aug; 67(15):7518-24. PubMed ID: 17671223
[TBL] [Abstract][Full Text] [Related]
15. CXCR4 heterogeneous expression in esophageal squamous cell cancer and stronger metastatic potential with CXCR4-positive cancer cells.
Lu CL; Guo J; Gu J; Ge D; Hou YY; Lin ZW; Ding JY
Dis Esophagus; 2014 Apr; 27(3):294-302. PubMed ID: 23822165
[TBL] [Abstract][Full Text] [Related]
16. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor.
Pelus LM; Bian H; Fukuda S; Wong D; Merzouk A; Salari H
Exp Hematol; 2005 Mar; 33(3):295-307. PubMed ID: 15730853
[TBL] [Abstract][Full Text] [Related]
17. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
[TBL] [Abstract][Full Text] [Related]
18. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer.
Saur D; Seidler B; Schneider G; Algül H; Beck R; Senekowitsch-Schmidtke R; Schwaiger M; Schmid RM
Gastroenterology; 2005 Oct; 129(4):1237-50. PubMed ID: 16230077
[TBL] [Abstract][Full Text] [Related]
19. Effective therapeutic targeting of the overexpressed HER-2 receptor in a highly metastatic orthotopic model of esophageal carcinoma.
Gros SJ; Kurschat N; Dohrmann T; Reichelt U; Dancau AM; Peldschus K; Adam G; Hoffman RM; Izbicki JR; Kaifi JT
Mol Cancer Ther; 2010 Jul; 9(7):2037-45. PubMed ID: 20606043
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
